James Kelly
Director of Finance/CFO at NOVAVAX, INC.
Net worth: 63 502 $ as of 2024-03-30
Profile
Presently, James Patrick Kelly holds the position of Chief Financial Officer, Treasurer & Executive VP of Novavax, Inc. He is also Member of The Association of Bioscience Financial Officers. In his past career he held the position of Chief Financial Officer, Treasurer & Executive VP for Vanda Pharmaceuticals, Inc., Chief Financial Officer & Executive Vice President at Supernus Pharmaceuticals, Inc., Director-Planning & Operations at Biogen, Inc., Principal at Aetna, Inc. and Vice President & Controller for MedImmune LLC. Mr. Kelly received an MBA from Cornell University and an undergraduate degree from the University of Vermont.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
NOVAVAX, INC.
0.01% | 2024-03-09 | 13,285 ( 0.01% ) | 63 502 $ | 2024-03-30 |
James Kelly active positions
Companies | Position | Start |
---|---|---|
NOVAVAX, INC. | Director of Finance/CFO | 2021-08-15 |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | - |
Former positions of James Kelly
Companies | Position | End |
---|---|---|
SUPERNUS PHARMACEUTICALS, INC. | Director of Finance/CFO | 2021-08-12 |
VANDA PHARMACEUTICALS INC. | Director of Finance/CFO | 2020-03-14 |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Comptroller/Controller/Auditor | 2010-11-30 |
BIOGEN INC. | Corporate Officer/Principal | 2005-10-31 |
AETNA | Corporate Officer/Principal | 2000-05-31 |
Training of James Kelly
Cornell University | Masters Business Admin |
University of Vermont | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
BIOGEN INC. | Health Technology |
NOVAVAX, INC. | Health Technology |
VANDA PHARMACEUTICALS INC. | Health Technology |
SUPERNUS PHARMACEUTICALS, INC. | Health Technology |
Private companies | 3 |
---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Aetna, Inc.
Aetna, Inc. Managed Health CareHealth Services Aetna, Inc. engages in the provision of traditional, voluntary, and consumer-directed health insurance products and related services. It offers benefits, products and services to individuals, employers, healthcare professionals, and producers. The company was founded by Eliphalet Adams Bulkeley in 1853 and is headquartered in Hartford, CT. | Health Services |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Commercial Services |
- Stock Market
- Insiders
- James Kelly